Thermo Fisher Scientific Inc. (TMO)
Pre-market:
| Previous close | 485.92 |
| Open | 489.89 |
| Bid | 0.00 x 800 |
| Ask | 502.00 x 800 |
| Day's range | 489.89 - 495.80 |
| 52-week range | 415.60 - 609.85 |
| Volume | |
| Avg. volume | 1,810,122 |
| Market cap | 190.45B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 32.26 |
| EPS (TTM) | 15.28 |
| Earnings date | 30 Jan 2024 - 03 Feb 2024 |
| Forward dividend & yield | 1.40 (0.28%) |
| Ex-dividend date | 14 Dec 2023 |
| 1y target est | 525.14 |
- Yahoo Finance Video
2024's most anticipated sectors outside of the Magnificent 7
Morgan Stanley (MS) outlines the top investment areas for 2024 outside of the dominant Magnificent Seven tech stocks. Yahoo Finance's Ines Ferré details the top sectors expected for 2024 based off trends seen this past year, including real estate, materials, and semiconductors. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Business WireThermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
WALTHAM, Mass., November 29, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of $2.5 billion aggregate principal amount (the "Offering") of the following notes:
Business WireThermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences
WALTHAM, Mass. & CAMBRIDGE, Mass., November 28, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Flagship Pioneering, the bioplatform innovation company, today announced the formation of a strategic partnership to develop and commercially scale multiproduct platforms on an accelerated basis.
